申请人:Nektar Therapeutics
公开号:US10434181B2
公开(公告)日:2019-10-08
The invention relates to (among other things) oligomer-containing benzamide-based compound compounds. A compound of the invention exhibits one or more advantages over corresponding compounds lacking the oligomer.
本发明涉及(除其他外)含有低聚物的苯甲酰胺基化合物。与缺乏低聚物的相应化合物相比,本发明的化合物具有一种或多种优点。